CXCL12 has emerged as a cytokine influencing neutrophil phenotype and potentially stroke severity, yet its effect in the acute phase remains controversial.<h4>Methods</h4>In this prospective cohort study, 134 patients with ischemic stroke within 6 h of onset or with a wake-up stroke were included. The gene discussed is CXCL12; the disease is stroke disorder.